EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSAPOG00000007439
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSAPOG00000004194
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor Type 5-Like

Ensembl ID : ENSAPOG00000002080
Gene Symbol: LOC110954137
2 Cross references
187 Possible Orthologues:

Sphingosine Kinase 2-Like

Ensembl ID : ENSAPOG00000015297
Gene Symbol: LOC110959704
2 Cross references
124 Possible Orthologues:

Sphingosine Kinase 2-Like

Ensembl ID : ENSAPOG00000021658
Gene Symbol: LOC110972468
2 Cross references
200 Possible Orthologues:

Sphingosine Kinase 2-Like

Ensembl ID : ENSAPOG00000019230
Gene Symbol: LOC110946442
2 Cross references
124 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSAPOG00000006499
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSAPOG00000012876
Gene Symbol: LOC110971264
3 Cross references
211 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSAPOG00000010136
Gene Symbol: SRD5A2B
1 Cross references
192 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSAPOG00000021701
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSAPOG00000017736
Gene Symbol: LOC110966764
3 Cross references
194 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSAPOG00000019778
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).